Literature DB >> 10687331

Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor.

G J Bennett1.   

Abstract

Pain is detected by two different types of peripheral nociceptor neurons, C-fiber nociceptors with slowly conducting unmyelinated axons, and A-delta nociceptors with thinly myelinated axons. During inflammation, nociceptors become sensitized, discharge spontaneously, and produce ongoing pain. Prolonged firing of C-fiber nociceptors causes release of glutamate which acts on N-methyl-D-aspartate (NMDA) receptors in the spinal cord. Activation of NMDA receptors causes the spinal cord neuron to become more responsive to all of its inputs, resulting in central sensitization. NMDA-receptor antagonists, such as dextromethorphan, can suppress central sensitization in experimental animals. NMDA-receptor activation not only increases the cell's response to pain stimuli, it also decrease neuronal sensitivity to opioid receptor agonists. In addition to preventing central sensitization, co-administration of NMDA-receptor antagonists with an opioid may prevent tolerance to opioid analgesia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10687331     DOI: 10.1016/s0885-3924(99)00120-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  49 in total

1.  Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.

Authors:  A M Hughes; J Rhodes; G Fisher; M Sellers; J W Growcott
Journal:  Br J Clin Pharmacol       Date:  2002-06       Impact factor: 4.335

2.  Effects of early atipamezole reversal of medetomidine-ketamine anesthesia in mice.

Authors:  Naomi J Baker; John C Schofield; Mark D Caswell; Alexander D McLellan
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-11       Impact factor: 1.232

3.  Analgesic effects of ketamine infusion therapy in korean patients with neuropathic pain: A 2-week, open-label, uncontrolled study.

Authors:  Jin Gu Kang; Chul Joong Lee; Tae Hyeong Kim; Woo Seok Sim; Byung Seop Shin; Sang Hyun Lee; Francis Sahngun Nahm; Pyung Bok Lee; Yong Chul Kim; Sang Chul Lee
Journal:  Curr Ther Res Clin Exp       Date:  2010-04

4.  Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain.

Authors:  James K McNamara; Nataliya Shinkazh; Fay Rim; Remy Sunga; Adrian Cristian
Journal:  P T       Date:  2011-02

5.  Low-dose ketamine provides poor analgesia for pain in redback spider envenoming.

Authors:  Nicole M Ryan; Rosemary James; Michael A Downes; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2019-08-06       Impact factor: 4.335

Review 6.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Complex Regional Pain Syndrome, Current Concepts and Treatment Options.

Authors:  Ivan Urits; Abra H Shen; Mark R Jones; Omar Viswanath; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-02-05

Review 8.  The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis.

Authors:  Jianli Zhao; Yajing Wang; Dajie Wang
Journal:  Curr Pain Headache Rep       Date:  2018-02-05

9.  L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration.

Authors:  Lusliany J Rondón; M C Farges; N Davin; B Sion; A M Privat; M P Vasson; A Eschalier; C Courteix
Journal:  Eur J Nutr       Date:  2017-07-19       Impact factor: 5.614

Review 10.  Predictors of clinical pain intensity in patients with fibromyalgia syndrome.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.